Controlled Clinical TrialiVNSn = 15

Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn's Disease Patients: A Prospective Open-label Study

D’Haens G, Eberhardson M, Cabrijan Z, Danese S, van den Berg R, Löwenberg M, Fiorino G, Schuurman PR, Lind G, Almqvist P, et al.

Journal of Crohn's and Colitis · 2023

Key finding

In a trial of 15 patients with Crohn's disease, VNS produced a clinically meaningful fall in disease-activity index and faecal calprotectin, with mucosal improvement in 11 of 15.

Auto-extracted · verification pendingHow we verify

Condition
Gut Health
Stimulation
iVNS
Evidence tier
Controlled Clinical Trial
Participants
15
View on DOI

Share this study

Download the citation card as a PNG, or copy a link to this page.

Cite this study

D’Haens, G., Eberhardson, M., Cabrijan, Z., Danese, S., van den Berg, R., Löwenberg, M., Fiorino, G., Schuurman, P. R., Lind, G., Almqvist, P., Olofsson, P. S., Tracey, K. J., Hanauer, S. B., Zitnik, R., Chernoff, D., & Levine, Y. A. (2023). Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn's Disease Patients: A Prospective Open-label Study. Journal of Crohn's and Colitis, 17(12), 1897-1909. https://doi.org/10.1093/ecco-jcc/jjad151

Related studies in Gut Health

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.